JP2009529906A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009529906A5 JP2009529906A5 JP2009500939A JP2009500939A JP2009529906A5 JP 2009529906 A5 JP2009529906 A5 JP 2009529906A5 JP 2009500939 A JP2009500939 A JP 2009500939A JP 2009500939 A JP2009500939 A JP 2009500939A JP 2009529906 A5 JP2009529906 A5 JP 2009529906A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- polypeptide
- protein according
- receptor
- fusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 22
- 102000004196 processed proteins & peptides Human genes 0.000 claims 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims 22
- 108020001507 fusion proteins Proteins 0.000 claims 18
- 102000037865 fusion proteins Human genes 0.000 claims 18
- 102000009109 Fc receptors Human genes 0.000 claims 8
- 108010087819 Fc receptors Proteins 0.000 claims 8
- 230000000890 antigenic effect Effects 0.000 claims 7
- 230000004927 fusion Effects 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 230000001717 pathogenic effect Effects 0.000 claims 3
- 230000003612 virological effect Effects 0.000 claims 3
- 108060003951 Immunoglobulin Proteins 0.000 claims 2
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 230000002538 fungal effect Effects 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 102000018358 immunoglobulin Human genes 0.000 claims 2
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 101710166488 6 kDa early secretory antigenic target Proteins 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 101710154606 Hemagglutinin Proteins 0.000 claims 1
- 241000711549 Hepacivirus C Species 0.000 claims 1
- 241000700721 Hepatitis B virus Species 0.000 claims 1
- 108010070875 Human Immunodeficiency Virus tat Gene Products Proteins 0.000 claims 1
- 241000712431 Influenza A virus Species 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 108010006232 Neuraminidase Proteins 0.000 claims 1
- 102000005348 Neuraminidase Human genes 0.000 claims 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 1
- 208000030852 Parasitic disease Diseases 0.000 claims 1
- 101710176177 Protein A56 Proteins 0.000 claims 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 claims 1
- 230000005867 T cell response Effects 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 230000008827 biological function Effects 0.000 claims 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 claims 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 1
- 239000000185 hemagglutinin Substances 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 claims 1
- 244000045947 parasite Species 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 1
- 125000006850 spacer group Chemical group 0.000 claims 1
- 241000712461 unidentified influenza virus Species 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0605735.0A GB0605735D0 (en) | 2006-03-22 | 2006-03-22 | Composition and method for mediating an immune response |
| PCT/GB2007/050143 WO2007107797A2 (en) | 2006-03-22 | 2007-03-22 | Fusion protein comprising an fc receptor binding polypeptide and an antigenic polypeptide for mediating an immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009529906A JP2009529906A (ja) | 2009-08-27 |
| JP2009529906A5 true JP2009529906A5 (enExample) | 2011-08-18 |
Family
ID=36383953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009500939A Pending JP2009529906A (ja) | 2006-03-22 | 2007-03-22 | 免疫応答を調節するための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20090186025A1 (enExample) |
| EP (1) | EP2007807A2 (enExample) |
| JP (1) | JP2009529906A (enExample) |
| CN (2) | CN101448854A (enExample) |
| GB (1) | GB0605735D0 (enExample) |
| WO (1) | WO2007107797A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0615266D0 (en) * | 2006-08-01 | 2006-09-06 | Immunobiology Ltd | Composition and method for mediating an immune response |
| CA2915168C (en) | 2007-01-30 | 2017-05-23 | Epivax, Inc. | Regulatory t cell epitopes, compositions and uses thereof |
| TWI422594B (zh) | 2007-02-02 | 2014-01-11 | Baylor Res Inst | 經由樹狀細胞去唾液酸糖蛋白受體(dc-asgpr)接合抗原呈現細胞之藥劑 |
| TWI423985B (zh) * | 2007-02-23 | 2014-01-21 | Baylor Res Inst | 利用dectin-1活化人類抗原呈現細胞之醫療應用 |
| WO2011044158A1 (en) | 2009-10-09 | 2011-04-14 | New York Blood Center, Inc. | Immunopotentiator-linked oligomeric influenza immunogenic compositions |
| AU2013295647B2 (en) * | 2012-07-26 | 2018-02-08 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Multimeric fusion protein vaccine and immunotherapeutic |
| CN106659774A (zh) | 2014-05-16 | 2017-05-10 | 贝勒研究院 | 用于治疗自身免疫和炎性病症的方法和组合物 |
| EP3253797A4 (en) * | 2015-02-03 | 2018-10-03 | Jyant Technologies, Inc. | Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof |
| CN106146670B (zh) * | 2015-04-24 | 2019-01-15 | 宜明昂科生物医药技术(上海)有限公司 | 一种新的重组双功能融合蛋白及其制备和应用 |
| CN106366179A (zh) * | 2016-08-28 | 2017-02-01 | 苏州普罗达生物科技有限公司 | 一种跨膜硫酸乙酰肝泰蛋白多糖1免疫激动剂多肽及其用途 |
| CN106366180A (zh) * | 2016-08-28 | 2017-02-01 | 苏州普罗达生物科技有限公司 | 一种上皮生长因子受体免疫原多肽及其用途 |
| CN106337040A (zh) * | 2016-08-28 | 2017-01-18 | 苏州普罗达生物科技有限公司 | 一种内皮细胞受体蛋白酪氨酸激酶a2免疫原多肽及其用途 |
| US20220073630A1 (en) * | 2018-12-28 | 2022-03-10 | Hoffmann-La Roche, Inc. | A peptide-mhc-i-antibody fusion protein for therapeutic use in a patient with amplified immune response |
| CN110093360B (zh) * | 2019-04-15 | 2021-06-15 | 华南农业大学 | 一种表达Fc片段的狂犬病病毒G蛋白的融合蛋白及其制备方法 |
| CN112870344B (zh) * | 2019-11-29 | 2022-07-19 | 北京绿竹生物技术股份有限公司 | 一种重组水痘带状疱疹病毒疫苗 |
| CN110872358B (zh) * | 2019-12-04 | 2021-12-10 | 天康制药(苏州)有限公司 | HA-Fc融合蛋白及其制备方法和疫苗 |
| CA3211083A1 (en) * | 2021-03-04 | 2022-09-09 | Kyle BACKMAN | Compositions including sbi adjuvants and methods of use thereof |
| CN116769014A (zh) * | 2023-06-07 | 2023-09-19 | 河南省农业科学院动物免疫学重点实验室 | 一种牛IgG Fc受体boFcγRI的线性配体结合表位 |
| CN119841940B (zh) * | 2025-03-19 | 2025-06-20 | 中国人民解放军军事科学院军事医学研究院 | 一种抗基孔肯雅病毒e蛋白的纳米抗体n033及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5969109A (en) * | 1990-02-28 | 1999-10-19 | Bona; Constantin | Chimeric antibodies comprising antigen binding sites and B and T cell epitopes |
| ATE204300T1 (de) * | 1994-05-13 | 2001-09-15 | Biovation Ltd | Zielzellen-bindende chimäre peptide |
| US6391589B1 (en) * | 1994-08-23 | 2002-05-21 | Human Genome Sciences, Inc. | Human chemokine beta-10 mutant polypeptides |
| EP1093464A2 (en) * | 1998-07-06 | 2001-04-25 | The University Of Tennessee Research Corporation | Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| US7183387B1 (en) * | 1999-01-15 | 2007-02-27 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US7067110B1 (en) * | 1999-07-21 | 2006-06-27 | Emd Lexigen Research Center Corp. | Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| ATE355374T1 (de) * | 2000-11-27 | 2006-03-15 | Praecis Pharm Inc | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen |
| GB0102145D0 (en) * | 2001-01-26 | 2001-03-14 | Scancell Ltd | Substances |
| US20040002587A1 (en) * | 2002-02-20 | 2004-01-01 | Watkins Jeffry D. | Fc region variants |
| US8025873B2 (en) * | 2002-06-20 | 2011-09-27 | Paladin Labs, Inc. | Chimeric antigens for eliciting an immune response |
| US8007805B2 (en) * | 2003-08-08 | 2011-08-30 | Paladin Labs, Inc. | Chimeric antigens for breaking host tolerance to foreign antigens |
-
2006
- 2006-03-22 GB GBGB0605735.0A patent/GB0605735D0/en not_active Ceased
-
2007
- 2007-03-22 JP JP2009500939A patent/JP2009529906A/ja active Pending
- 2007-03-22 WO PCT/GB2007/050143 patent/WO2007107797A2/en not_active Ceased
- 2007-03-22 EP EP07733568A patent/EP2007807A2/en not_active Withdrawn
- 2007-03-22 US US12/225,454 patent/US20090186025A1/en not_active Abandoned
- 2007-03-22 CN CNA2007800185186A patent/CN101448854A/zh active Pending
- 2007-03-22 CN CN2013102732781A patent/CN103396495A/zh active Pending
-
2012
- 2012-05-11 US US13/470,227 patent/US20120225067A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009529906A5 (enExample) | ||
| JP6882184B2 (ja) | 多価b型肝炎ウイルス抗原結合分子およびその使用 | |
| HRP20210876T1 (hr) | Anti-tmprss2 antitijela i fragmenti koji vezuju antigen | |
| Park et al. | Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells | |
| EP3094644B1 (en) | Neutralizing human monoclonal antibodies against hepatitis b virus surface antigen | |
| JP2017527272A5 (enExample) | ||
| KR102706285B1 (ko) | 항 인터페론 감마 항체 및 그의 용도 | |
| US10654915B2 (en) | Antibodies useful in passive influenza immunization | |
| JP2010521147A5 (enExample) | ||
| JP2011509245A5 (enExample) | ||
| JP2016512213A5 (enExample) | ||
| JP2010502207A5 (enExample) | ||
| CA2963470A1 (en) | Antibodies that bind ebola glycoprotein and uses thereof | |
| CN107108721B (zh) | 包含hiv-1包膜靶向臂的双特异性分子 | |
| RU2016129724A (ru) | Антитела, содержащие с-концевые удлинения полипептида легкой цепи, их конъюгаты и способы применения | |
| JP2017534296A5 (enExample) | ||
| Mendoza et al. | Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rγc KO. NOD) | |
| RU2016135962A (ru) | Выделенное антитело, способ его получения, выделенная нуклеиновая кислота, экспрессионная кассета, клетка-хозяин, фармацевтический и диагностический препараты, способ лечения больного, подверженного риску или страдающего от инфекции E.COLI, и способ диагностики определения инфекций E.COLI | |
| US20230293652A1 (en) | Immunostimulatory adjuvants | |
| JP2019511457A5 (enExample) | ||
| JP2018537117A5 (enExample) | ||
| Zhang et al. | Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus | |
| AU2017226955A1 (en) | Polypeptide library | |
| JP2012510802A (ja) | 完全ヒトインフルエンザm2特異的抗体 | |
| CA3196069A1 (en) | Immune composition comprising antigen and glycoengineered antibody thereof |